Gene · 926
Papers3,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies. | EMBO Mol Med | 2023 | 37522383 | PubTator, text mining | PubMed |
| Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for the Re-Emerging Human Monkeypox Virus. | J Microbiol Biotechnol | 2023 | 37519276 | PubTator, text mining | PubMed |
| ROGUE: an R Shiny app for RNA sequencing analysis and biomarker discovery. | BMC Bioinformatics | 2023 | 37516886 | PubTator, text mining | PubMed |
| Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study. | Vaccines (Basel) | 2023 | 37515009 | PubTator, text mining | PubMed |
| Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. | Microorganisms | 2023 | 37512809 | PubTator, text mining | PubMed |
| Immune Cells Localize to Sites of Corneal Erosions in C57BL/6 Mice. | Biomolecules | 2023 | 37509096 | PubTator, text mining | PubMed |
| Evaluating imputation methods for single-cell RNA-seq data. | BMC Bioinformatics | 2023 | 37507764 | PubTator, text mining | PubMed |
| Clostridium perfringens Epsilon Toxin Binds to and Kills Primary Human Lymphocytes. | Toxins (Basel) | 2023 | 37505692 | PubTator, text mining | PubMed |
| Immune cell identifier and classifier (ImmunIC) for single cell transcriptomic readouts. | Sci Rep | 2023 | 37495649 | PubTator, text mining | PubMed |
| New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy. | Cell Death Dis | 2023 | 37495596 | PubTator, text mining | PubMed |
| Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial. | Nat Med | 2023 | 37488287 | PubTator, text mining | PubMed |
| Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients. | Front Immunol | 2023 | 37483622 | PubTator, text mining | PubMed |
| Primary oxidative phosphorylation defects lead to perturbations in the human B cell repertoire. | Front Immunol | 2023 | 37483601 | PubTator, text mining | PubMed |
| Annexin A2: the missing piece in the puzzle of pathogen-induced damage. | Virulence | 2023 | 37482693 | PubTator, text mining | PubMed |
| The activity of cuproptosis pathway calculated by AUCell algorithm was employed to construct cuproptosis landscape in lung adenocarcinoma. | Discov Oncol | 2023 | 37481739 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance. | Commun Biol | 2023 | 37479893 | PubTator, text mining | PubMed |
| IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer. | Br J Surg | 2023 | 37478362 | PubTator, text mining | PubMed |
| Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review. | J Cancer | 2023 | 37476189 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma. | Pathol Oncol Res | 2023 | 37475874 | PubTator, text mining | PubMed |
| GHRL as a prognostic biomarker correlated with immune infiltrates and progression of precancerous lesions in gastric cancer. | Front Oncol | 2023 | 37469414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/926/papers?page=17